Pacira Pharmaceuticals buy Jefferies Financial Group Inc.
Start price
24.09.24
/
50%
€12.60
Target price
24.09.25
€16.13
Performance (%)
-0.79%
Price
26.09.24
€12.50
Summary
This prediction is currently active. Since the start of the prediction for Pacira Pharmaceuticals the price has only changed by -0.79%. This prediction currently runs until 24.09.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Pacira Pharmaceuticals | -0.79% |
| iShares Core DAX® | 1.518% |
| iShares Nasdaq 100 | 1.240% |
| iShares Nikkei 225® | 2.808% |
| iShares S&P 500 | 0.403% |
Comments by Jefferies_Financial_ for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target raised by analysts at Jefferies Financial Group Inc. from $15.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat